CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

skezan

07/23/2025 11:31:55 PM

CNPV fun facts: FAQs: Commissioners (8)

HouseofCards

07/23/2025 9:39:53 PM

We can still sell like 250M shares if (2)

mfglola

07/23/2025 9:11:09 PM

So FDA is now accepting applications (8)

biloxiblues

07/23/2025 8:29:23 PM

We will be fine! (2)

sean007

07/23/2025 8:01:14 PM

Money is never out of (4)

Mr3Putt

07/23/2025 6:35:43 PM

Thoughts? Upwithstock IIRC has (5)

bucweey34

07/23/2025 6:08:28 PM

Question for those with more knowledge (1)

Buddyboy20

07/23/2025 5:50:30 PM

"I still vividly remember the sharp (8)

sean007

07/23/2025 5:43:23 PM

"Beneath the surface"...remains the (1)

KenChowder

07/23/2025 5:29:34 PM

Sherlock, companies who make tender (6)

sjacobs26

07/23/2025 4:41:02 PM

I could be off here, but considering (10)

sherlock57

07/23/2025 3:57:35 PM

Sunray--Imagine the response of the (18)

cardamine

07/23/2025 3:07:08 PM

Wiki even makes a separate section for (2)

cardamine

07/23/2025 2:53:12 PM

yeah there's been the proverbial "blood (1)

sunray3

07/23/2025 1:12:31 PM

Oh, I'm sure as I suspect you are that (7)

twinter11

07/23/2025 12:57:30 PM

"I don't pretend to know the motives (7)

sunray3

07/23/2025 12:07:51 PM

Now mind you, I don't pretend to know (3)

sunray3

07/23/2025 11:11:08 AM

Definitely BS, you're right...the MM (7)

Tprovo

07/23/2025 10:43:31 AM

Gap filled at .28 this AM and so did my (2)

Evil Rabbit

07/23/2025 10:03:41 AM

That premarket action was some BS. 11k (6)

dfwl28

07/23/2025 9:55:10 AM

Side effects of Ipilimumab, also known (4)

ohm20

07/23/2025 4:01:10 AM

Ipilimumab Safety Profile: Associated (16)

ohm20

07/23/2025 3:50:15 AM

Based on above hypothesis, It could (11)

KenChowder

07/23/2025 3:13:18 AM

MGK wrote: Based on above hypothesis, (11)

ohm20

07/23/2025 2:56:21 AM

Sorry Ohm, I'm not smart enough to (13)

USS JOHNSTON

07/22/2025 11:27:56 PM

I am also not a doctor, biloxi, so I (5)

MGK_2

07/22/2025 8:09:36 PM

I wrote (4)

biloxiblues

07/22/2025 7:37:02 PM

I am not a Doctor, but this is (4)

craigakess

07/22/2025 7:24:09 PM

Thanks for posting the response. (5)

Mr3Putt

07/22/2025 7:05:07 PM

UWS responds to you at r/Livimmune: (3)

SeeWhyDY

07/22/2025 5:49:35 PM

Am I reading this article (2)

skezan

07/22/2025 4:42:55 PM

Sorry Ohm, I'm not smart enough to (2)

ohm20

07/22/2025 3:34:27 PM

Ipilimumab is an antibody that binds to (10)

craigakess

07/22/2025 1:50:53 PM

Thanks for posting that as it is quite (6)

craigakess

07/22/2025 1:36:36 PM

Strange that it says the study was (2)

sean007

07/22/2025 1:34:19 PM

Europe Not entire (1)

Boatbuilder

07/22/2025 1:15:30 PM

Unfortunately not CYDY. (2)

docj

07/22/2025 12:28:38 PM

Good to see your post. It has been a

KenChowder

07/22/2025 11:16:35 AM

Another poster corrected me on the time (4)

Mr3Putt

07/22/2025 10:44:56 AM

The Jun 24 PR stated that the company (8)

sunray3

07/22/2025 10:36:07 AM

Well, I must admit that's a compelling (11)

Jake2212

07/22/2025 9:25:56 AM

sunray: Sounds good, but keep in mind. (10)

hoops

07/22/2025 9:23:24 AM

There is hope. (3)

KenChowder

07/22/2025 9:15:17 AM

Yes, that Reddit post is worth a read. (12)

sunray3

07/22/2025 9:05:38 AM

Agree, and as you say the acquirer must (11)

sherlock57

07/22/2025 4:42:15 AM

Thanks, 3Putt, for posting that. It's (22)

Mr3Putt

07/21/2025 10:31:35 PM

Require reading for the frustrated (14)

Ramjet

07/21/2025 8:24:56 PM

Agreed, months and years. I feel for (11)

sean007

07/21/2025 7:36:01 PM

"There is no crying in (2)

ohm20

07/21/2025 5:38:01 PM

Unfortunately, the ESMO presentations (20)

Newer

Older

Recent Articles

• Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
• Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
• Google's Decision to Shift Women Techmakers Program Sparks Controversy
• Podiatry Content Connection Unveils Innovative AI Solutions
• zerohash Europe Gets MiCAR Authorization for Crypto Services
• Tech Titans' Dinner Sparks Fried Chicken Stock Boom
• The Rise of the Silver American Eagle: Why Stackers Are Going All In
• Tenaris Launches $600 Million in Share Buyback for Investors
• Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
• Tenaris Launches $600 Million in Share Buybacks Amid Growth
• Exploring AI Adoption Among Small Businesses Across The U.S.
• Shiba Inu ETF Filing Sparks Significant Token Burn Event
• Investors of Avantor, Inc. Encouraged to Seek Justice Together
• Al Salam Bank Commemorates ASB Capital's Successful Year
• Tom Lee: The Trusted Face of Ethereum in the Finance World
• Elon Musk and Sam Altman: The Roadster Refund Debate
• Navigating Career Transitions: Insights from Industry Experts
• Key Steps for Fortinet, Inc. Investors Ahead of Class Action
• Air Traffic Controllers Face Staffing Crisis Amid Shutdown
• Warren Challenges Trump on Rising Costs Affecting Families
• James Hardie Industries Investors Invited to Join Critical Lawsuit
• Fluor Corporation's Investors Encouraged to Act Now for Justice
• Bitcoin Surges to $100K Amidst Market Challenges and Insights
• Ziegler Successfully Completes $44M Financing for Frasier
• Lowe's Contributes $1 Million for Hurricane Recovery in Jamaica
• Celebrate Dodgers' Triumph with New Era's 2025 Collection
• Richmond Terrace Capital Launches New €1.5 Billion Investment Fund
• Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing
• Sequoia Capital Launches $950M Fund to Fuel AI Innovators
• Virginia Veterans Celebrate with Free Book Vouchers for Stories
• Innovative Advancements of Poain BlockEnergy in Global DeFi Market
• Investors of aTyr Pharma Should Secure Legal Help Now
• Bahrain Premieres Revolutionary Rooftop Solar Power Initiative
• Deqing's Pearl Mussel Award: A Mark of Agricultural Heritage
• Buck Sexton Unveils the Dawn of America’s Next Wealth Era
• Navigating the Promising Journey of Mutuum Finance and MUTM
• Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
• Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
• Top Stock Insights: Palantir's Surge and Pfizer's Struggles
• The Last Messages of Charlie Kirk Revealing His Fears
• Significant Stock Declines: Fiserv, eBay, and Garmin Under Pressure
• Major Moves in Tech: Earnings Reports & Market Trends Ahead
• Ford Faces Major Recall Challenges But Sees Opportunities Ahead
• Discover the Hidden Gems: Stocks Gaining Investor Interest
• OncoHost Showcases Innovative Insights in NSCLC Proteomics
• Mutuum Finance Gears Up for Exciting V1 Launch with $18M Raised
• Apple's Impressive Earnings, Bold Future Predictions Unveiled
• Fangzhou's Innovative AI Solutions Transform Chronic Care Management
• Fangzhou Innovates Chronic Disease Management with AI Solutions
• CoorsTek Bioceramics Triumphs in Legal Right to Market Hip Components